All Relations between basal ganglia and dopamine

Publication Sentence Publish Date Extraction Date Species
Thomas V Wiecki, Michael J Fran. Neurocomputational models of motor and cognitive deficits in Parkinson's disease. Progress in brain research. vol 183. 2010-12-27. PMID:20696325. the loss of dopaminergic neurons innervating the striatum in pd, and the well-established role of dopamine (da) in reinforcement learning (rl), enable neural network models of the basal ganglia (bg) to derive concrete and testable predictions. 2010-12-27 2023-08-12 Not clear
Meinou H de Vries, Catrin Ulte, Pienie Zwitserlood, Barbara Szymanski, Stefan Knech. Increasing dopamine levels in the brain improves feedback-based procedural learning in healthy participants: an artificial-grammar-learning experiment. Neuropsychologia. vol 48. issue 11. 2010-12-08. PMID:20600185. recently, an increasing number of studies have suggested a role for the basal ganglia and related dopamine inputs in procedural learning, specifically when learning occurs through trial-by-trial feedback (shohamy, myers, kalanithi, & gluck. 2010-12-08 2023-08-12 human
Meinou H de Vries, Catrin Ulte, Pienie Zwitserlood, Barbara Szymanski, Stefan Knech. Increasing dopamine levels in the brain improves feedback-based procedural learning in healthy participants: an artificial-grammar-learning experiment. Neuropsychologia. vol 48. issue 11. 2010-12-08. PMID:20600185. basal ganglia and dopamine contributions to probabilistic category learning. 2010-12-08 2023-08-12 human
Nicola Pavese, Vinod Metta, Subrata K Bose, Kallol Ray Chaudhuri, David J Brook. Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction. Brain : a journal of neurology. vol 133. issue 11. 2010-11-30. PMID:20884645. we used ¹⁸f-dopa and ¹¹c-dasb [n,n-dimethyl-2-(2-amino-4-cyanophenylthio) benzylamine] positron emission tomography, markers of dopamine storage capacity and serotonin transporter availability, to investigate whether fatigue in parkinson's disease is associated with dopaminergic and serotonergic dysfunction in basal ganglia and limbic circuits. 2010-11-30 2023-08-12 Not clear
Emma Thornton, Tuyet T B Tran, Robert Vin. A substance P mediated pathway contributes to 6-hydroxydopamine induced cell death. Neuroscience letters. vol 481. issue 1. 2010-11-08. PMID:20599590. the neurotoxin 6-hydroxydopamine (6-ohda) is used to induce dopaminergic cell death, resulting in insufficient striatal dopamine content in the basal ganglia and motor dysfunction typical of parkinson's disease. 2010-11-08 2023-08-12 Not clear
Peter Redgrave, Manuel Rodriguez, Yoland Smith, Maria C Rodriguez-Oroz, Stephane Lehericy, Hagai Bergman, Yves Agid, Mahlon R DeLong, Jose A Obes. Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease. Nature reviews. Neuroscience. vol 11. issue 11. 2010-11-08. PMID:20944662. in patients with parkinson's disease the loss of dopamine is predominantly in the posterior putamen, a region of the basal ganglia associated with the control of habitual behaviour. 2010-11-08 2023-08-12 Not clear
Kimberly A McDowell, Maria M Hadjimarkou, Shaun Viechweg, Avigail E Rose, Sarah M Clark, Paul J Yarowsky, Jessica A Mon. Sleep alterations in an environmental neurotoxin-induced model of parkinsonism. Experimental neurology. vol 226. issue 1. 2010-10-28. PMID:20713046. parkinson's disease (pd) is classically defined as a motor disorder resulting from decreased dopamine production in the basal ganglia circuit. 2010-10-28 2023-08-12 rat
Li Jijun, Li Zaiwang, Li Anyuan, Wang Shuzhen, Qi Fanghua, Zhao Lin, Lv Hon. Abnormal expression of dopamine and serotonin transporters associated with the pathophysiologic mechanism of Tourette syndrome. Neurology India. vol 58. issue 4. 2010-10-26. PMID:20739786. however, recent studies provide evidence implicating metabolic abnormalities of dopamine (da) and serotonin (5-ht) of the basal ganglia both in ts patients and ts animal models. 2010-10-26 2023-08-12 Not clear
Sergi Ferré, Carme Lluís, Zuzana Justinova, César Quiroz, Marco Orru, Gemma Navarro, Enric I Canela, Rafael Franco, Steven R Goldber. Adenosine-cannabinoid receptor interactions. Implications for striatal function. British journal of pharmacology. vol 160. issue 3. 2010-10-14. PMID:20590556. in this review we will focus on their common role as modulators of dopamine and glutamate neurotransmission in the striatum, the main input structure of the basal ganglia. 2010-10-14 2023-08-12 Not clear
Martine van Schouwenburg, Esther Aarts, Roshan Cool. Dopaminergic modulation of cognitive control: distinct roles for the prefrontal cortex and the basal ganglia. Current pharmaceutical design. vol 16. issue 18. 2010-10-08. PMID:20370667. conversely, other studies highlight a role for dopamine in the basal ganglia in cognitive switching, which might reflect a modulation of the selective gating of cortical cognitive and motor programs. 2010-10-08 2023-08-12 Not clear
Salvatore Galati, Vincenza D'Angelo, Enrica Olivola, Francesco Marzetti, Giuseppe Di Giovanni, Paolo Stanzione, Alessandro Stefan. Acute inactivation of the medial forebrain bundle imposes oscillations in the SNr: a challenge for the 6-OHDA model? Experimental neurology. vol 225. issue 2. 2010-10-01. PMID:20615405. hence, our data support the proposition that lfo, is tightly correlated to cortex, and represent a critical hallmark of a basal ganglia (bg) failure from the early stages of dopamine denervation. 2010-10-01 2023-08-12 rat
M Lafreniere-Roula, O Darbin, W D Hutchison, T Wichmann, A M Lozano, J O Dostrovsk. Apomorphine reduces subthalamic neuronal entropy in parkinsonian patients. Experimental neurology. vol 225. issue 2. 2010-10-01. PMID:20659454. dopamine depletion in parkinson's disease (pd) alters the neuronal activity in basal ganglia circuits. 2010-10-01 2023-08-12 Not clear
Fabrizio Stocch. Dopamine receptor agonists in the treatment of advanced Parkinson's disease. Parkinsonism & related disorders. vol 15 Suppl 4. 2010-09-30. PMID:20123558. there is now accumulating evidence that the progressive pathology of pd, the change in drug pharmaco-dynamics, and the pulsatile manner in which short-acting dopaminergic agents stimulate striatal dopamine receptors combine as key contributing factors to the priming of the basal ganglia for induction of motor complications. 2010-09-30 2023-08-12 Not clear
Sergi Ferré, Gemma Navarro, Vicent Casadó, Antoni Cortés, Josefa Mallol, Enric I Canela, Carme Lluís, Rafael Franc. G protein-coupled receptor heteromers as new targets for drug development. Progress in molecular biology and translational science. vol 91. 2010-09-28. PMID:20691958. dopamine and opioid receptor heteromers are the focus of intense research which is related to the possible multiple applications of their putative ligands in pathological conditions, which include basal ganglia disorders, schizophrenia and drug addiction. 2010-09-28 2023-08-12 Not clear
Alireza M Nayebi, Siyamak R Rad, Mehdi Saberian, Saeid Azimzadeh, Morteza Samin. Buspirone improves 6-hydroxydopamine-induced catalepsy through stimulation of nigral 5-HT(1A) receptors in rats. Pharmacological reports : PR. vol 62. issue 2. 2010-09-27. PMID:20508280. receptors for 5-ht(1a) are widely distributed throughout the basal ganglia, and their activation results in an inhibition of dopamine (da) release. 2010-09-27 2023-08-12 rat
K Fuxe, D Marcellino, D O Borroto-Escuela, M Guescini, V Fernández-Dueñas, S Tanganelli, A Rivera, F Ciruela, L F Agnat. Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS neuroscience & therapeutics. vol 16. issue 3. 2010-09-22. PMID:20345970. thus, other pathogenic mechanisms beside the well-known alterations in the release and/or decoding of dopamine in the basal ganglia and limbic system are involved in pd, schizophrenia and drug addiction. 2010-09-22 2023-08-12 Not clear
Véronique M André, Carlos Cepeda, Michael S Levin. Dopamine and glutamate in Huntington's disease: A balancing act. CNS neuroscience & therapeutics. vol 16. issue 3. 2010-09-22. PMID:20406248. significant evidence indicates that glutamate and dopamine neurotransmission is affected in hd, compromising the fine balance in which da modulates glutamate-induced excitation in the basal ganglia and cortex. 2010-09-22 2023-08-12 Not clear
Alexxai V Kravitz, Benjamin S Freeze, Philip R L Parker, Kenneth Kay, Myo T Thwin, Karl Deisseroth, Anatol C Kreitze. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature. vol 466. issue 7306. 2010-09-21. PMID:20613723. here we report direct activation of basal ganglia circuitry in vivo, using optogenetic control of direct- and indirect-pathway medium spiny projection neurons (msns), achieved through cre-dependent viral expression of channelrhodopsin-2 in the striatum of bacterial artificial chromosome transgenic mice expressing cre recombinase under control of regulatory elements for the dopamine d1 or d2 receptor. 2010-09-21 2023-08-12 mouse
Siroos Mirzaei, Rasoul Zakavi, Margarida Rodrigues, Thomas Schwarzgruber, Thomas Brücke, Jiri Bakala, Katalin Borbély, Norbert Leners, Peter Knoll, Rene Donne. Fully automated 3D basal ganglia activity measurement in dopamine transporter scintigraphy (Spectalyzer). Annals of nuclear medicine. vol 24. issue 4. 2010-09-10. PMID:20232177. fully automated 3d basal ganglia activity measurement in dopamine transporter scintigraphy (spectalyzer). 2010-09-10 2023-08-12 Not clear
Siroos Mirzaei, Rasoul Zakavi, Margarida Rodrigues, Thomas Schwarzgruber, Thomas Brücke, Jiri Bakala, Katalin Borbély, Norbert Leners, Peter Knoll, Rene Donne. Fully automated 3D basal ganglia activity measurement in dopamine transporter scintigraphy (Spectalyzer). Annals of nuclear medicine. vol 24. issue 4. 2010-09-10. PMID:20232177. semiquantitative evaluation of tracer uptake in basal ganglia is superior to visual assessment of images in dopamine transporter (dat) scintigraphy especially in follow-up of the patients. 2010-09-10 2023-08-12 Not clear